Literature DB >> 10448336

Changing patterns of HIV related ocular disease.

S Rauz1, P I Murray.   

Abstract

Cytomegalovirus (CMV) retinitis is the commonest ocular complication of AIDS and the prevention of recurrence has been dependent on lifelong maintenance treatment. Recently there has been a dramatic downturn in the number of new cases of CMV retinitis, which has been attributed to the introduction of highly active antiretroviral therapy (HAART) and subsequent improved survival. Whereas paucity of inflammation has been considered to be the hallmark of the ophthalmic manifestations of AIDS, with immune recovery, a new pattern of ophthalmic AIDS has emerged. This is characterised by a heightened inflammatory response and more frequent complications associated with this response--for example, vitritis, cystoid macular oedema. In spite of this, regression of CMV retinitis has been reported, as well as absence of reactivation or progression after withdrawal of anti-CMV maintenance treatment. How long this situation will continue is not known and we remain cautious about the future of CMV retinitis and other opportunistic ocular infections.

Entities:  

Mesh:

Year:  1999        PMID: 10448336      PMCID: PMC1758167          DOI: 10.1136/sti.75.1.18

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  46 in total

1.  Cystoid macular edema due to cytomegalovirus retinitis in a patient with acquired immune deficiency syndrome.

Authors:  D V Weinberg; R S Moorthy
Journal:  Retina       Date:  1996       Impact factor: 4.256

2.  Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

Authors:  M A Jacobson; M Zegans; P R Pavan; J J O'Donnell; F Sattler; N Rao; S Owens; R Pollard
Journal:  Lancet       Date:  1997-05-17       Impact factor: 79.321

Review 3.  AIDS and ophthalmology: a period of transition.

Authors:  D A Jabs; J G Bartlett
Journal:  Am J Ophthalmol       Date:  1997-08       Impact factor: 5.258

4.  Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis.

Authors:  S M Whitcup; E Fortin; R B Nussenblatt; M A Polis; C Muccioli; R Belfort
Journal:  JAMA       Date:  1997-05-21       Impact factor: 56.272

5.  Physicians face new contradictions in HIV care.

Authors:  R Voelker
Journal:  JAMA       Date:  1997-05-21       Impact factor: 56.272

6.  Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis.

Authors:  J L Davis; I Taskintuna; W R Freeman; D V Weinberg; W J Feuer; R E Leonard
Journal:  Arch Ophthalmol       Date:  1997-06

7.  HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

Authors:  M Connors; J A Kovacs; S Krevat; J C Gea-Banacloche; M C Sneller; M Flanigan; J A Metcalf; R E Walker; J Falloon; M Baseler; I Feuerstein; H Masur; H C Lane
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

8.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

9.  Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.

Authors:  J B Reed; I R Schwab; J Gordon; L S Morse
Journal:  Am J Ophthalmol       Date:  1997-08       Impact factor: 5.258

10.  Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups.

Authors:  R W Coombs; S L Welles; C Hooper; P S Reichelderfer; R T D'Aquila; A J Japour; V A Johnson; D R Kuritzkes; D D Richman; S Kwok; J Todd; J B Jackson; V DeGruttola; C S Crumpacker; J Kahn
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

View more
  4 in total

1.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

2.  The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy.

Authors:  S Varani; P Spezzacatena; R Manfredi; F Chiodo; A Mastroianni; P Ballarini; A Boschini; T Lazzarotto; M P Landini
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

3.  Postmortem histological survey of the ocular lesions in a British population of AIDS patients.

Authors:  I Pecorella; A Ciardi; A Garner; A C McCartney; S Lucas
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

4.  Ocular complications in HIV positive patients on antiretroviral therapy in Ghana.

Authors:  Alexander Martin-Odoom; Evelyn Yayra Bonney; Derek Kofi Opoku
Journal:  BMC Ophthalmol       Date:  2016-08-03       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.